Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Rangering i aksjer #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Aksjekurs
$2.10
Sist synkronisert: 2026-08-21
Markedsverdi
$104.43M
Endring (1 dag)
-2.10%
Endring (1 år)
-
Land
US
Handel Polaryx Therapeutics, Inc. Common Stock (PLYX)

Kategori

Aksjeprishistorikk for Polaryx Therapeutics, Inc. Common Stock (PLYX)
Høyeste sluttskurs: $2.23 den 2026-08-01

Laveste sluttskurs: $7.90 den 2026-02-01
Aksjeprishistorikk for Polaryx Therapeutics, Inc. Common Stock fra 2026 til 2026
Årlig aksjeprisytelse
År Ytelse
Ikke nok data for de angitte datoene.
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH